Cancer Therapeutic Effects of Titanium Dioxide Nanoparticles Are Associated with Oxidative Stress and Cytokine Induction.
Nanoparticles (NPs) are considered to influence the inflammatory process; however, the precise mechanism and the significance in tumors are still not clear. In this study, when CT26 and LL2 mouse cancer cells were treated with 6-nm anatase titanium dioxide NPs (TDNPs) without ultraviolet irradiation, oxidative stress and induction of inflammatory cytokines were observed. Oxidative stress was further increased by disease-associated conditions such as high glucose concentrations and hypoxia. Inhaled or orally administered TDNPs generated granulomatous lesions in the lungs and colon of the rodent models tested, with increased oxidative stress and inflammatory cytokines. Oxidative stress and inflammatory cytokines were also found in cancer cells treated with gold or carbon black NPs. Treatment of CT26 cells with 10- to 70-nm rutile TDNPs showed that smaller NPs produced more oxidative stress and inflammatory cytokines than larger ones did. To avoid diffusion of TDNPs and to minimize toxicity, 10-nm TDNPs were suspended in a collagen gel inserted into a subcutaneous tumor in a CT26 mouse. A single TDNP treatment via this method inhibited tumor growth in a size- and dose-dependent manner, and resulted in lower levels of urinary 8-OHdG when compared to systemically administered TDNPs. These findings suggest that TDNPs might be useful for the local treatment of tumors.
Department of Molecular Pathology, Nara Medical University, Kashihara, Japan.
Rina
R
Fujiwara
Yi
Y
Luo
Takamitsu
T
Sasaki
Kiyomu
K
Fujii
Hitoshi
H
Ohmori
Hiroki
H
Kuniyasu
D000080242:8-Hydroxy-2'-Deoxyguanosine; D000818:Animals; D015687:Cell Hypoxia; D045744:Cell Line, Tumor; D003106:Colon / Q000187:drug effects / Q000473:pathology; D016207:Cytokines / Q000096:biosynthesis* / Q000276:immunology; D003849:Deoxyguanosine / Q000031:analogs & derivatives / Q000652:urine; D004195:Disease Models, Animal; D004333:Drug Administration Routes; D006046:Gold / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D008168:Lung / Q000187:drug effects / Q000276:immunology / Q000473:pathology; D053768:Metal Nanoparticles / Q000737:chemistry / Q000627:therapeutic use* / Q000633:toxicity*; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy; D018384:Oxidative Stress; D051381:Rats; D053260:Soot / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D014025:Titanium / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity*; D014466:Ultraviolet Rays
D016207:Cytokines; D053260:Soot; C009495:titanium dioxide; D006046:Gold; D000080242:8-Hydroxy-2'-Deoxyguanosine; D014025:Titanium; D003849:Deoxyguanosine